Irreversible, cell permeable, biotin-labelled inhibitor of cysteine proteases.
Product Specification
Alternative Name: | Dibenzyl-1-[(R)-biotin-6-aminohexanoyl-aziridine]-2,3-(S,S+R,R)-dicarboxylate |
|
Formula: | C34H42N4O7S |
|
MW: | 650.8 |
|
CAS: | 744207-03-2 |
|
Purity: | ≥98% (HPLC) |
|
Appearance: | White to yellow solid. |
|
Solubility: | Soluble in DMSO (50mg/ml), 100% ethanol or methanol. |
|
Shipping: | Ambient |
|
Long Term Storage: | -20°C |
|
Handling: | Protect from light. |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles: U. Schurigt, et al.; Antimicrob. Agents Chemother.
54, 5028 (2010),
Abstract;
Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells: C. Gelhaus, et al.; Biol. Chem.
386, 499 (2005),
Abstract;
Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate: C. Gelhaus, et al.; Biol. Chem.
385, 435 (2004),
Abstract;